...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Use of hydrophobins in formulation of water insoluble drugs for oral administration
【24h】

Use of hydrophobins in formulation of water insoluble drugs for oral administration

机译:疏水蛋白在水不溶性药物口服制剂中的用途

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The poor water solubility of many drugs requires a specific formulation to achieve a sufficient bioavailability after oral administration. Suspensions of small drug particles can be used to improve the bioavailability. We here show that the fungal hydrophobin SC3 can be used to make suspensions of water insoluble drugs. Bioavailability of two of these drugs, nifedipine and cyclosporine A (CyA), was tested when administered as a SC3-based suspension. SC3 (in a 1:2 (w/w) drug:SC3 ratio) or 100% PEG400 increased the bioavailability of nifedipine to a similar degree (6±2- and 4±3-fold, respectively) compared to nifedipine powder without additives. Moreover, SC3 (in a 7:1 (w/w) drug:hydrophobin ratio) was as effective as a 20-fold diluted Neoral formulation by increasing bioavailability of CyA 2.3±0.3- fold compared to CyA in water. Interestingly, using SC3 in the CyA formulation resulted in a slower uptake (p < 0.001 in Tmax) of the drug, with a lower peak concentration (Cmax 1.8mgml-1) at a later time point (Tmax 9±2 h) compared to Neoral (Cmax 2.2mgml-1; Tmax 3.2±0.2). Consequently, SC3 will result in a more constant, longer lasting drug level in the body. Taken together, hydrophobins are attractive candidates to formulate hydrophobic drugs.
机译:许多药物的水溶性差,需要特定的配方才能在口服后达到足够的生物利用度。药物小颗粒的悬浮液可用于提高生物利用度。我们在这里表明,真菌疏水蛋白SC3可用于制备水不溶性药物的悬浮液。当以基于SC3的混悬液形式给药时,对其中两种药物硝苯地平和环孢霉素A(CyA)的生物利用度进行了测试。与不含添加剂的硝苯地平粉末相比,SC3(药物与SC3的比例为1:2(w / w))或100%PEG400可将硝苯地平的生物利用度提高至相似的程度(分别为6±2和4±3倍) 。此外,与水中的CyA相比,SC3(以7:1(w / w)的药物:疏水蛋白比例)与20倍稀释的Neoral制剂一样有效,其CyA的生物利用率提高了2.3±0.3倍。有趣的是,在CyA制剂中使用SC3导致药物的吸收较慢(在Tmax中p <0.001),而在较晚的时间点(Tmax 9±2 h)具有较低的峰值浓度(Cmax 1.8mgml-1)。神经性(Cmax 2.2mgml-1; Tmax 3.2±0.2)。因此,SC3将导致体内更恒定,更持久的药物水平。总之,疏水蛋白是配制疏水性药物的有吸引力的候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号